Business Services · Miscellaneous Commercial Services · NSE: SYNGENE · data 2026-10-31
Syngene International Ltd.
In plain words
Price: 40.7% below its 52-week high of ₹678.95.
Delivery: 45.7% of traded shares were kept for delivery over the last 10 sessions, against 52.9% over the last 60.
Latest results: a net profit of ₹32 cr for the quarter ended Sept 2026 (-52.0% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹3,522 cr |
| Net profit (last 12 months) | ₹186 cr |
| Sales growth, 3 years (yearly) | 5.5% |
| Profit growth, 3 years (yearly) | -12.0% |
At a glance
Promoters 52.6% (-0.1 pts in a year), pledged 0.0%, institutions 39.4%.
P/E 87.2, P/B 3.3, dividend yield 0.3%. Price relative to earnings and book value (low is cheaper, not better).
ROE 6.6%, ROCE 9.9%, operating margin 13.0%: how much profit it earns on the money it uses.
Debt/equity 0.09, Profit growth -12.0% and sales growth 5.5% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Low return on equity (6.6%).
- Profit fell 12.0% a year over 3 years.
- Expensive on earnings (P/E 87.2).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
SYNGENE Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹832.7 crore, down 8.6% YoY and up 13.1% QoQ.
Net profit was ₹32.2 crore, down 52% YoY and a turn to profit from a loss last quarter.
Operating margin was 17.7% (21.9% a year ago).
EPS was ₹0.8, down 52.1% YoY and positive against a negative EPS last quarter.
SYNGENE के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹832.7 करोड़; पिछले साल की तुलना में 8.6% की गिरावट, पिछली तिमाही की तुलना में 13.1% की बढ़त।
शुद्ध मुनाफ़ा: ₹32.2 करोड़; पिछले साल की तुलना में 52% की गिरावट, पिछली तिमाही के घाटे से मुनाफ़े में आया।
ऑपरेटिंग मार्जिन: 17.7% (एक साल पहले 21.9%)।
EPS: ₹0.8; पिछले साल की तुलना में 52.1% की गिरावट, पिछली तिमाही के ऋणात्मक EPS से धनात्मक हुआ।
SYNGENEના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹832.7 કરોડ; ગયા વર્ષની સરખામણીએ 8.6% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 13.1% વધારો.
ચોખ્ખો નફો: ₹32.2 કરોડ; ગયા વર્ષની સરખામણીએ 52% ઘટાડો, ગયા ક્વાર્ટરની ખોટમાંથી નફામાં આવી.
ઓપરેટિંગ માર્જિન: 17.7% (એક વર્ષ પહેલાં 21.9%).
EPS: ₹0.8; ગયા વર્ષની સરખામણીએ 52.1% ઘટાડો, ગયા ક્વાર્ટરના નકારાત્મક EPSથી હકારાત્મક થઈ.
Written from the filed numbers. Not a recommendation.
Smart-money activity
27/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 9/30: Delivery 24.1% over the last 20 sessions vs 56.1% in the 40 before (0.43x); shares delivered per day 1.63x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 11/15: 11 schemes hold it, about ₹1,332 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 2/15: Verdict "None", sustained score 53/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend
- 27 Oct 26Results Q2 FY27 results: profit −52.0% YoY +14.2% next session
- 29 Jul 26Results Q1 FY27 results: turned to loss vs a year ago -2.4% next session
- 25 Jun 26Dividend Dividend ₹1.25 (ex-date) -2.0% next session
- 29 Apr 26Results Q4 FY26 results: profit −19.3% YoY +6.2% next session
- 22 Jan 26Results Q3 FY26 results: profit −88.6% YoY -9.5% next session
- 5 Nov 25Results Q2 FY26 results: profit −36.8% YoY -4.0% next session
- 23 Jul 25Results Q1 FY26 results: profit +14.5% YoY -0.9% next session
- 27 Jun 25Dividend Dividend ₹1.25 (ex-date) -1.1% next session
- 24 Apr 25Results Q4 FY25 results: profit −2.8% YoY -15.9% next session
- 23 Jan 25Results Q3 FY25 results: profit +17.6% YoY -3.9% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹833 cr | ₹32 cr | -52.0% | 17.7% | 0.8 |
| Jun 2026 | ₹736 cr | ₹-9 cr | -110.4% | 12.3% | -0.22 |
| Mar 2026 | ₹1,037 cr | ₹148 cr | -19.3% | 29.3% | 3.68 |
| Dec 2025 | ₹917 cr | ₹15 cr | -88.6% | 22.8% | 0.37 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 52.59% | 52.59% | 52.68% | 52.68% |
| Foreign institutions (FII) | 10.14% | 11.82% | 13.90% | 14.96% |
| Domestic institutions (DII) | 29.30% | 28.02% | 26.44% | 25.84% |
| Mutual funds | 27.10% | 25.78% | 24.18% | 22.71% |
| Retail investors | 4.95% | 4.77% | 4.21% | 3.93% |
| Number of shareholders | 1,34,008 | 1,42,277 | 1,35,605 | 1,31,750 |
Common questions
What was Syngene International Ltd.'s latest quarterly profit?
Syngene International Ltd. reported a net profit of ₹32 cr for the quarter ended Sept 2026 (-52.0% on the same quarter a year earlier), on revenue of ₹833 cr.
How much do promoters hold in Syngene International Ltd.?
Promoters held 52.59% of Syngene International Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Syngene International Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.09, which is very low.
What is Syngene International Ltd.'s P/E ratio?
About 87.2, based on the last 12 months' earnings and a price of ₹402.7 (data 2026-10-31).
What is the 52-week high and low of Syngene International Ltd.?
The 52-week high is ₹678.95 and the 52-week low is ₹344.45.
Mutual funds holding Syngene International Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 11 schemes holding about ₹1,332 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| NIPPON INDIA SMALL CAP FUND | Nippon India Mutual Fund | 0.60% | ₹485 cr |
| SBI Multi Asset Allocation Fund | SBI Mutual Fund | 1.22% | ₹257 cr |
| Nippon India Focused Fund | Nippon India Mutual Fund | 2.71% | ₹219 cr |
| NIPPON INDIA PHARMA FUND | Nippon India Mutual Fund | 1.40% | ₹128 cr |
| Mirae Asset Focused Fund | Mirae Asset Mutual Fund | 1.85% | ₹118 cr |
| SBI Healthcare Opportunities Fund | SBI Mutual Fund | 1.12% | ₹66 cr |
| Nippon India Innovation Fund | Nippon India Mutual Fund | 1.64% | ₹48 cr |
| ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND | Aditya Birla Sun Life Mutual Fund | 0.64% | ₹7 cr |
| ADITYA BIRLA SUN LIFE NIFTY SMALLCAP 50 INDEX FUND | Aditya Birla Sun Life Mutual Fund | 0.82% | ₹3 cr |
| Nippon India MNC Fund | Nippon India Mutual Fund | 0.46% | ₹2 cr |
| Mirae Asset Nifty 500 Healthcare ETF | Mirae Asset Mutual Fund | 0.51% | ₹0 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Syngene International Ltd. | ₹402.7 | ₹16,252 cr | 87.2 | 3.3 | 6.6% | 9.9% | 0.09 | -38.7% |
| Sagility Limited | ₹42.08 | ₹19,662 cr | 19.2 | 1.9 | 10.3% | 12.4% | 0.11 | -21.3% |
| International Gemological Institute Ltd | ₹397.75 | ₹17,181 cr | 26.7 | 9.8 | 44.6% | 51.8% | 0.1 | +17.3% |
| Choice International Limited | ₹721.35 | ₹16,072 cr | 65.9 | — | 16.1% | — | 0.54 | -12.2% |
| eClerx Services Limited | ₹1,556.7 | ₹14,641 cr | 20.3 | 4.9 | 29% | 31.2% | 0.15 | -32.8% |
| Concord Biotech Ltd. | ₹1,245.6 | ₹13,028 cr | 46.1 | 6.3 | 13.6% | 15.1% | 0 | -14.4% |
Compare SYNGENE with SAGILITY in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SYNGENE in NSE Scanner →